Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Griptha Putra Persada Tbk. (GRPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Griptha Putra Persada Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 308B, 43.3K 24h volume), while Griptha Putra Persada Tbk. trades at Rp62 (market cap 59B, 6.31M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 5.2× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (6.31M versus 43.3K). Which is the better fit depends on your goals.
| DGNS | GRPH | |
|---|---|---|
Market Cap | 308B | 59B |
Volume | 43.3K | 6.31M |
Lot | 433 | 63.06K |
Turnover | 9.77M | 390.74M |
Average Price | 225.57 | 61.96 |
Value | 9.77M | 390.74M |
Indicative Equilibrium Price | 230 | 60 |
Indicative Equilibrium Volume | 110 | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Griptha Putra Persada Tbk.
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →
